John A. Stalfort III - 16 Aug 2023 Form 4 Insider Report for Taysha Gene Therapies, Inc. (TSHA)

Role
Director
Signature
/s/ Kamran Alam, Attorney-in-Fact
Issuer symbol
TSHA
Transactions as of
16 Aug 2023
Net transactions value
+$700,000
Form type
4
Filing time
16 Aug 2023, 20:53:51 UTC
Previous filing
26 Jun 2023
Next filing
31 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TSHA Common Stock Purchase $350,000 +388,889 +78% $0.9000 884,290 16 Aug 2023 See footnote F1
transaction TSHA Common Stock Purchase $350,000 +388,889 +64% $0.9000 999,381 16 Aug 2023 Direct
transaction TSHA Common Stock Gift $0 +50,000 +5% $0.000000 1,049,381 16 Aug 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities are held by Gineane Holly Stalfort, as Trustee of the John A. Stalfort III 2018 Irrevocable Trust under agreement dated as of October 25, 2018.